RxDoctor Payments DataLook up a doctor →

Carrie Cobb, MD

Dermatology · Lynchburg, VANPI 1770732232

Payments from drug & device makers

$859,432in general payments, 2019–2025

Across 496 payments — averaging $1732.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$691K
  • Pfizer$65K
  • Amgen$55K
  • Vanda Pharmaceuticals Inc.$41K
  • Sanofi Pasteur Inc.$3K
  • Sanofi$908
  • plus $3K from 23 others
$2,925in research payments, 2019–2025

Across 1 payment — averaging $2925.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$3K

What the payments were for

  • Food & beverage$7,93499%
  • Education$441%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$859,432 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia

Medicare billing

Part B allowed, 2024
$351,375
Medicare patients
1,318
Services billed
5,560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa17$374,728
Fluorouracil39$2,948
Ketoconazole170$2,232
Clobetasol Propionate68$2,129
Doxycycline Hyclate61$1,505
Metronidazole35$1,501
Triamcinolone Acetonide153$1,260
Betamethasone Dipropionate28$1,255
CiclopiroxCiclopirox Olamine31$1,176
Fluocinolone AcetonideFluocinolone/Shower Cap12$1,128
Fluocinonide25$831
Hydrocortisone89$774
Clindamycin Phosphate23$747
Doxepin Hcl16$705
Fluconazole26$586

Paid to pharmacies, not to this prescriber.

Other dermatology in Lynchburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →